Immune Design Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
1,599.00
6,433.00
9,510.00
13,260.00
7,195.00
Cost of Goods Sold (COGS) incl. D&A
669.00
638.00
774.00
481.00
435.00
Gross Income
930.00
5,795.00
8,736.00
12,779.00
6,760.00
SG&A Expense
15,987.00
35,673.00
48,221.00
61,143.00
59,572.00
EBIT
15,057.00
29,878.00
39,485.00
48,364.00
52,812.00
Unusual Expense
955.00
4,277.00
-
5,850.00
-
Pretax Income
15,975.00
34,151.00
39,445.00
53,530.00
51,862.00
Consolidated Net Income
15,975.00
34,151.00
39,445.00
53,530.00
51,862.00
Net Income
15,975.00
34,151.00
39,445.00
53,530.00
51,862.00
Net Income After Extraordinaries
15,975.00
34,151.00
39,445.00
53,530.00
51,862.00
Net Income Available to Common
15,975.00
34,151.00
39,445.00
53,530.00
51,862.00
EPS (Basic)
0.95
4.56
2.06
2.47
1.75
Basic Shares Outstanding
16,876.20
7,494.80
19,155.90
21,638.50
29,626.90
EPS (Diluted)
0.95
4.56
2.06
2.47
1.75
Diluted Shares Outstanding
16,876.20
7,494.80
19,155.90
21,638.50
29,626.90
EBITDA
14,650.00
29,640.00
39,242.00
48,060.00
52,461.00
Non-Operating Interest Income
37.00
4.00
40.00
684.00
950.00
About Immune Design
View Profile
